Plasma Therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and then transfusing antibodies into a patient to kickstart the immune system. The immune system produces antibodies to fight infection and sufficient antibodies can help the person recover.
Plasma therapy aims at building a sick person's immunity, wherein, antibodies are transferred from healthy to the sick person. Convalescent plasma is referred to as the liquid part of blood. The therapy involves transferring plasma from blood to fight the disease.
Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events than those getting standard care.
Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.
India's top medical research body -- Indian Council of Medical Research (ICMR) on Wednesday said that indiscriminate use of Convalescent Plasma Therapy (CPT) should be avoided as it does not reduce mortality in COVID-19 patients.